Sawai Lays Out Ten Year Goals Including ¥400bn In Revenues
Plans Include Almost Doubling US Revenues From Upsher-Smith
Japan’s Sawai has laid out its mid- and long-term ambitions in a new company business plan, spanning both its local and overseas operations.
You may also be interested in...
Sawai’s Upsher-Smith Gets New Leadership Amid ‘Drastic Restructuring’
A major overhaul is in progress for Sawai’s Upsher-Smith business, after the Japanese parent company announced leadership changes and a “drastic restructuring” of the US unit in the wake of a significant impairment charge and a hefty annual operating loss that dragged down Sawai’s overall results.
Sprycel And Vidaza Generics Among Five First-Times For Sawai
Fresh from announcing a major deal that will see it take over a network of facilities, Japanese player Sawai says its aim is to “further increase production by strengthening the personnel structure.”
Sawai To Take Over Facilities Owned By Scandal-Hit Kobayashi Kako
Kobayashi Kako has agreed to transfer ownership of eight of its production, research and distribution facilities to Sawai, which will use them to expand the manufacturing of its own generics. Business was suspended at Kobayashi Kako for 116 days this year after the company’s manufacturing deficiencies were linked to two deaths.